Interleukin 33 is a guardian of barriers and a local alarmin

[1]  K. Khosrotehrani,et al.  ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis , 2016, Experimental dermatology.

[2]  R. Waal Malefyt,et al.  IL‐33 promotes innate IFN‐γ production and modulates dendritic cell response in LCMV‐induced hepatitis in mice , 2015, European journal of immunology.

[3]  C. Gabay,et al.  The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. , 2015, Cytokine.

[4]  T. Mustelin,et al.  Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation , 2015, Nature Communications.

[5]  Mousa Komai Koma,et al.  Interleukin‐33 Triggers B1 Cell Expansion and Its Release of Monocyte/Macrophage Chemoattractants and Growth Factors , 2015, Scandinavian journal of immunology.

[6]  S. Zheng,et al.  Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation. , 2015, Journal of molecular cell biology.

[7]  G. Nilsson,et al.  Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma , 2015, PloS one.

[8]  H. Hammad,et al.  Barrier Epithelial Cells and the Control of Type 2 Immunity. , 2015, Immunity.

[9]  C. Akdis,et al.  An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. , 2015, Immunity.

[10]  O. Sundnes,et al.  Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences. , 2015, The Journal of investigative dermatology.

[11]  Seamus J. Martin,et al.  Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. , 2015, Immunity.

[12]  R. Morita,et al.  AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites , 2015, Proceedings of the National Academy of Sciences.

[13]  Richard T. Lee,et al.  Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33 , 2015, Proceedings of the National Academy of Sciences.

[14]  Stephanie K. Doerner,et al.  IL-33 activates tumor stroma to promote intestinal polyposis , 2015, Proceedings of the National Academy of Sciences.

[15]  A. Jaffe,et al.  Soluble ST2--analytical considerations. , 2015, The American journal of cardiology.

[16]  J. Januzzi,et al.  The biology of ST2: the International ST2 Consensus Panel. , 2015, The American journal of cardiology.

[17]  C. Helmstetter,et al.  T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses , 2015, Proceedings of the National Academy of Sciences.

[18]  Song Ho Chang,et al.  Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium/calmodulin-dependent protein kinase 2 , 2015, Proceedings of the National Academy of Sciences.

[19]  I. Smirnov,et al.  The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury , 2015, Neuron.

[20]  H. Kita,et al.  Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation , 2015, Current opinion in allergy and clinical immunology.

[21]  C. Gabay,et al.  Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33–Overexpressing CMV/IL33 Mice , 2015, The Journal of Immunology.

[22]  Yutong Zhao,et al.  Focal Adhesion Kinase–Mediated Activation of Glycogen Synthase Kinase 3β Regulates IL-33 Receptor Internalization and IL-33 Signaling , 2015, The Journal of Immunology.

[23]  Srikanth S. Manda,et al.  Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling , 2015, Proteomics.

[24]  M. Nawijn,et al.  The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. , 2015, Molecular immunology.

[25]  T. Oshima,et al.  Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis , 2015, Journal of Gastroenterology.

[26]  M. Holtzman,et al.  Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells. , 2014, Annals of the American Thoracic Society.

[27]  J. Bessa,et al.  Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. , 2014, Journal of autoimmunity.

[28]  H. Turnquist,et al.  IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells , 2014, The Journal of Immunology.

[29]  J. Girard,et al.  Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells , 2014, Proceedings of the National Academy of Sciences.

[30]  N. Barrett,et al.  Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses. , 2014, The Journal of allergy and clinical immunology.

[31]  C. Gabay,et al.  Immune-mediated experimental arthritis in IL-33 deficient mice. , 2014, Cytokine.

[32]  M. Humbert,et al.  Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. , 2014, Biochemical and biophysical research communications.

[33]  B. Li,et al.  Deubiquitination and stabilization of IL-33 by USP21. , 2014, International journal of clinical and experimental pathology.

[34]  Yasmine Belkaid,et al.  The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.

[35]  D. Vaux,et al.  RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.

[36]  Y. Lau,et al.  IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut☆ , 2014, Journal of autoimmunity.

[37]  Y. Ohshima,et al.  IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes , 2014, BioMed research international.

[38]  W. Liu,et al.  IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling. , 2014, Molecular human reproduction.

[39]  T. Aune,et al.  Expression of IL-33 and its epigenetic regulation in multiple sclerosis , 2014, Annals of clinical and translational neurology.

[40]  J. Hasday,et al.  IFN-γ Directly Controls IL-33 Protein Level through a STAT1- and LMP2-dependent Mechanism* , 2014, The Journal of Biological Chemistry.

[41]  B. Ryffel,et al.  Interleukin-33 Increases Antibacterial Defense by Activation of Inducible Nitric Oxide Synthase in Skin , 2014, PLoS pathogens.

[42]  A. Lane,et al.  Damage‐associated molecular patterns stimulate interleukin‐33 expression in nasal polyp epithelial cells , 2014, International forum of allergy & rhinology.

[43]  Harinder Singh,et al.  Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation , 2013, Nature Communications.

[44]  C. Garlanda,et al.  Negative regulatory receptors of the IL-1 family. , 2013, Seminars in immunology.

[45]  Michael U. Martin.  Special aspects of interleukin-33 and the IL-33 receptor complex. , 2013, Seminars in immunology.

[46]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[47]  Meijuan Zhou,et al.  Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1 , 2013, Nature Immunology.

[48]  Susan M. Schlenner,et al.  Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation* , 2013, The Journal of Biological Chemistry.

[49]  A. L'helgoualc'h,et al.  Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis , 2013, PloS one.

[50]  R. Pierce,et al.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. , 2013, The Journal of clinical investigation.

[51]  S. Pflugfelder,et al.  Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation , 2013, Mucosal Immunology.

[52]  J. Tainer,et al.  Structural insights into the interaction of IL-33 with its receptors , 2013, Proceedings of the National Academy of Sciences.

[53]  S. Tominaga,et al.  Expression of IL-33 in the epidermis: The mechanism of induction by IL-17. , 2013, Journal of dermatological science.

[54]  L. Lopetuso,et al.  Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease , 2013, Front. Immunol..

[55]  G. Maurer,et al.  Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature , 2013, Journal of molecular and cellular cardiology.

[56]  Uma M. Muthurajan,et al.  The role of the nucleosome acidic patch in modulating higher order chromatin structure , 2013, Journal of The Royal Society Interface.

[57]  R. Thangavel,et al.  Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases , 2013, Journal of Neuroimmune Pharmacology.

[58]  M. Wittmann,et al.  Evidence for a regulatory loop between IFN‐γ and IL‐33 in skin inflammation , 2013, Experimental dermatology.

[59]  M. Vatn,et al.  Interleukin‐33 drives a proinflammatory endothelial activation that selectively targets non‐quiescent cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[60]  G. Nilsson,et al.  Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. , 2013, Blood.

[61]  Dirk E. Smith,et al.  Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency , 2013, Arthritis Research & Therapy.

[62]  L. O’Neill,et al.  The GOLD Domain-containing Protein TMED1 Is Involved in Interleukin-33 Signaling* , 2013, The Journal of Biological Chemistry.

[63]  Harinder Singh,et al.  Transcription factor IRF 4 drives dendritic cells to promote Th 2 differentiation , 2013 .

[64]  C. Trautwein,et al.  TRAIL but not FasL and TNFα, regulates IL‐33 expression in murine hepatocytes during acute hepatitis , 2012, Hepatology.

[65]  S. Tominaga,et al.  Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes. , 2012, The Journal of investigative dermatology.

[66]  G. Multhoff,et al.  Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells. , 2012, Cytokine.

[67]  S. Tominaga,et al.  Novel splice variants of IL-33: differential expression in normal and transformed cells. , 2012, The Journal of investigative dermatology.

[68]  C. Cayrol,et al.  Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. , 2012, European cytokine network.

[69]  A. Bellini,et al.  IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma. , 2012, Biochemical and biophysical research communications.

[70]  I. Udalova,et al.  The alarmin IL-33 is a notch target in quiescent endothelial cells. , 2012, The American journal of pathology.

[71]  S. Ben-Neriah,et al.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. , 2012, Blood.

[72]  Bill B. Chen,et al.  F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation , 2012, Nature Immunology.

[73]  S. Vogel,et al.  Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists , 2012, The Journal of Immunology.

[74]  Hai-Feng Zhang,et al.  Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress , 2012, Journal of Translational Medicine.

[75]  T. Himi,et al.  Regulation of interleukin‐33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines , 2012, The Laryngoscope.

[76]  J. Park,et al.  Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. , 2012, Biochemical and biophysical research communications.

[77]  Wei-hua Zhao,et al.  Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4. , 2012, Cytokine.

[78]  G. Nilsson,et al.  Mast Cells Respond to Cell Injury through the Recognition of IL-33 , 2012, Front. Immun..

[79]  P. Mercier,et al.  Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain , 2012, The Journal of Immunology.

[80]  F. Liew,et al.  IL-33: a Janus cytokine , 2012, Annals of the rheumatic diseases.

[81]  S. Nakae,et al.  The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses , 2012, Science.

[82]  B. Monsarrat,et al.  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G , 2012, Proceedings of the National Academy of Sciences.

[83]  Richard T. Lee,et al.  Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells* , 2012, The Journal of Biological Chemistry.

[84]  C. Gabay,et al.  The mouse interleukin (Il)33 gene is expressed in a cell type‐ and stimulus‐dependent manner from two alternative promoters , 2012, Journal of leukocyte biology.

[85]  安岡 智子.  Production and functions of IL-33 in the central nervous system , 2012 .

[86]  Dirk E. Smith,et al.  Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. , 2012, The Journal of allergy and clinical immunology.

[87]  H. Togashi,et al.  Prostaglandin E(2) enhances IL-33 production by dendritic cells. , 2011, Immunology letters.

[88]  K. Isse,et al.  IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival , 2011, The Journal of Immunology.

[89]  H. Togashi,et al.  Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells , 2011, Brain, Behavior, and Immunity.

[90]  De-Quan Li,et al.  TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. , 2011, The international journal of biochemistry & cell biology.

[91]  M. Schmitz,et al.  The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.

[92]  Ashley M. Miller,et al.  The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease. , 2011, Pharmacology & therapeutics.

[93]  Ashley M. Miller,et al.  IL‐33 induces skin inflammation with mast cell and neutrophil activation , 2011, European journal of immunology.

[94]  V. Julia,et al.  NKT cells are required to induce high IL‐33 expression in hepatocytes during ConA‐induced acute hepatitis , 2011, European journal of immunology.

[95]  G. Halliday,et al.  The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. , 2011, The American journal of pathology.

[96]  B. Ryffel,et al.  IL‐33‐activated dendritic cells are critical for allergic airway inflammation , 2011, European journal of immunology.

[97]  M. Kawaguchi,et al.  Expression and Effects of IL-33 and ST2 in Allergic Bronchial Asthma: IL-33 Induces Eotaxin Production in Lung Fibroblasts , 2011, International Archives of Allergy and Immunology.

[98]  T. Mcclanahan,et al.  Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. , 2011, International immunology.

[99]  C. Gabay,et al.  Interleukin-33 biology with potential insights into human diseases , 2011, Nature Reviews Rheumatology.

[100]  Shijie Jin,et al.  Production and functions of IL-33 in the central nervous system , 2011, Brain Research.

[101]  The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses , 2011, The Journal of Immunology.

[102]  Soohyun Kim,et al.  Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant* , 2011, The Journal of Biological Chemistry.

[103]  D. Heymann,et al.  IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. , 2011, Cytokine.

[104]  F. Liew,et al.  IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity , 2011, The Journal of Immunology.

[105]  Dirk E. Smith,et al.  Innate lymphoid cells responding to IL-33 mediate airway- hyperreactivity independent of adaptive immunity , 2011 .

[106]  M. Vatn,et al.  Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. , 2010, The American journal of pathology.

[107]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[108]  C. Lassen,et al.  Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein , 2010, Proceedings of the National Academy of Sciences.

[109]  P. Bryce,et al.  IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation , 2010, PloS one.

[110]  Zhang Lianfeng,et al.  Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. , 2010, Immunology letters.

[111]  P. Preshaw,et al.  Expression and regulation of interleukin‐33 in human monocytes , 2010, Immunology.

[112]  Thomas Kamradt,et al.  The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. , 2010, Blood.

[113]  Wei-hua Zhao,et al.  The enigmatic processing and secretion of interleukin-33 , 2010, Cellular and Molecular Immunology.

[114]  Q. Hamid,et al.  Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.

[115]  L. O’Neill,et al.  Localisation and trafficking of Toll-like receptors: an important mode of regulation. , 2010, Current opinion in immunology.

[116]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[117]  B. Vainer,et al.  IL-33 is upregulated in colonocytes of ulcerative colitis. , 2010, Immunology letters.

[118]  W. Falk,et al.  Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. , 2010, Biochemical and biophysical research communications.

[119]  R. Flavell,et al.  Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages1 , 2009, The Journal of Immunology.

[120]  A. Thomson,et al.  IL‐33 broadens its repertoire to affect DC , 2009, European journal of immunology.

[121]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[122]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[123]  Andreas Lingel,et al.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes. , 2009, Structure.

[124]  Mingcai Li,et al.  Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. , 2009, Biochemical and biophysical research communications.

[125]  K. Zhao,et al.  IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells , 2009, Proceedings of the National Academy of Sciences.

[126]  S. Cullen,et al.  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. , 2009, Immunity.

[127]  Bohan Wang,et al.  IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. , 2009, Biochemical and biophysical research communications.

[128]  J. Girard,et al.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.

[129]  C. Gabay,et al.  Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage* , 2009, The Journal of Biological Chemistry.

[130]  J. Pollheimer,et al.  Interleukin-33 - cytokine of dual function or novel alarmin? , 2009, Trends in immunology.

[131]  H. Kita,et al.  IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.

[132]  Dirk E. Smith,et al.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. , 2009, Arthritis and rheumatism.

[133]  J. Girard,et al.  The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.

[134]  L. Roussel,et al.  Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket , 2008, EMBO reports.

[135]  J. Pollheimer,et al.  Vascular Biology , Atherosclerosis and Endothelium Biology Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation , 2010 .

[136]  D. Lawrence,et al.  Induction of IL‐33 expression and activity in central nervous system glia , 2008, Journal of leukocyte biology.

[137]  I. McInnes,et al.  IL-33 exacerbates antigen-induced arthritis by activating mast cells , 2008, Proceedings of the National Academy of Sciences.

[138]  Dirk E. Smith,et al.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. , 2008, Cytokine.

[139]  M. Huber,et al.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells , 2007, Proceedings of the National Academy of Sciences.

[140]  M. Hayakawa,et al.  Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.

[141]  R. Kastelein,et al.  IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.

[142]  Richard T. Lee,et al.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.

[143]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[144]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[145]  Richard T. Lee,et al.  Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction , 2004, Circulation.

[146]  C. Stansberg,et al.  The interleukin 1 receptor family. , 2004, Developmental and comparative immunology.

[147]  Richard T. Lee,et al.  Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction , 2004, Circulation.

[148]  E. S. Baekkevold,et al.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.

[149]  G Sullivan,et al.  Variations on a Common Theme? , 2001, Journal of homosexuality.

[150]  K. Takakura,et al.  Identification of Genes Differentially Expressed in Canine Vasospastic Cerebral Arteries after Subarachnoid Hemorrhage , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[151]  Larry L. Constantine,et al.  Back to the future , 2001, CACM.

[152]  T. Rülicke,et al.  T1‐deficient and T1‐Fc‐transgenic mice develop a normal protective Th2‐type immune response following infection with Nippostrongylus brasiliensis , 2000, European journal of immunology.

[153]  D. J. Matthews,et al.  T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses , 2000, The Journal of experimental medicine.

[154]  S. Akira,et al.  The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function , 1999, The Journal of experimental medicine.

[155]  C. Meisel,et al.  Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses , 1999, The Journal of experimental medicine.

[156]  R. Klemenz,et al.  The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. , 1998, Journal of immunology.

[157]  Andreas Radbruch,et al.  T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[158]  F. Liew,et al.  Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells , 1998, The Journal of experimental medicine.

[159]  R. Klemenz,et al.  Transcription of the Interleukin-1 Receptor-related T1 Gene Is Initiated at Different Promoters in Mast Cells and Fibroblasts (*) , 1996, The Journal of Biological Chemistry.

[160]  S. Tominaga,et al.  Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1 , 1993, FEBS letters.

[161]  J. B. Williams,et al.  Growth factor-induced delayed early response genes , 1992, Molecular and cellular biology.

[162]  G. Superti-Furga,et al.  Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[163]  Shinobu Tominaga.  A putative protein of a growth specific cDNA from BALB/C‐3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor , 1989, FEBS letters.

[164]  R. Klemenz,et al.  Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[165]  M. Grütter,et al.  Crystal structure of the cytokine interleukin‐1 beta. , 1988, The EMBO journal.

[166]  K. Frei,et al.  [Interleukin 1]. , 1985, Schweizerische medizinische Wochenschrift.